Biomarkers in Mild Stages of Alzheimer’s disease: Utility in clinical practice and their relation with nutritional and lifestyle factors

Authors

  • Carol Dillon
  • Patricio Pérez Leguizamon
  • Silvina Heisecke
  • Diego M. Castro
  • Jorge Lopez Camelo
  • Leandro Lon
  • Cecilia M. Serrano
  • Veronica Guelar
  • Fernando E. Taragano

DOI:

https://doi.org/10.31989/ffhd.v6i10.299

Abstract

Background: The use of biomarkers in basic and clinical research as well as in clinical practice has become so common that their presence as primary endpoints in clinical trials is now accepted. A biomarker refers to a broad subcategory of medical signs. The aims of this article are to consider the of use biomarkers in Mild stages of Alzheimer’s disease (AD) in research and clinical settings, in addition to defining their utility in clinical practice relating this with nutritional and lifestyle factors as possible treatment.

Methods: We searched MEDLINE, PubMed, and AgeLine databases using different keywords.

Conclusions: A summary of the utility of biomarkers in AD and nutritional and lifestyle factors used as treatment in mild stages are described.

Key words: Biomarkers, Alzheimer’s disease, Dementia, Utility, Clinical practice, Nutritional

Downloads

Published

2016-10-31

Issue

Vol. 6 No. 10 (2016): October 2016

Section

Review Articles

License

Any manuscripts or substantial parts of it, submitted to the journal must not be under consideration by or previously published in any other journal or citable form. Authors are required to ensure that no material submitted as part of a manuscript infringes existing copyrights or the rights of a third party. In submitting one's article in any form, the author has assigned the FFC publishing rights and has agreed to an automatic transfer of the copyright to the publisher. This is so that the FFC may create print option journals, for example, at the FFC’s discretion. If the author wishes to distribute their works by means outside of the FFC, for example within their community, they will have to place a request. 

 

Correspondence concerning articles published in Functional Foods in Health and Disease is encouraged. While derivative works (adaptations, extensions on the current work, etc.) are allowed, distribution of the modified material is not allowed without permission from the FFC.